DermTech Inc

6.50+0.2700+4.33%Vol 2.95M1Y Perf -86.16%
Jun 24th, 2022 16:00 DELAYED
BID5.70 ASK6.76
Open6.33 Previous Close6.23
Pre-Market- After-Market6.50
 - -  - -%
Target Price
26.75 
Analyst Rating
Strong Buy 1.00
Potential %
311.54 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     56.48
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
5.26 
Earnings Rating
Market Cap194.61M 
Earnings Date
3rd Aug 2022
Alpha0.00 Standard Deviation0.29
Beta1.15 

Today's Price Range

6.126.55

52W Range

4.1848.32

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
35.42%
1 Month
1.25%
3 Months
-50.27%
6 Months
-63.81%
1 Year
-86.16%
3 Years
-68.45%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
DMTK6.500.27004.33
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
14.20
14.40
0.10
0.11
-73.90
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
7.00
-722.70
-702.60
-
-
RevenueValueIndustryS&P 500US Markets
13.03M
0.44
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.85-1.01-18.82
Q04 2021-0.73-0.88-20.55
Q03 2021-0.65-0.68-4.62
Q02 2021-0.54-0.4811.11
Q01 2021-0.47-0.49-4.26
Q04 2020-0.54-0.4811.11
Q03 2020-0.58-0.5013.79
Q04 2019--0.08-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date3rd Aug 2022
Estimated EPS Next Report-1.02
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume2.95M
Shares Outstanding29.94K
Shares Float22.85M
Trades Count9.43K
Dollar Volume19.09M
Avg. Volume1.30M
Avg. Weekly Volume1.90M
Avg. Monthly Volume1.10M
Avg. Quarterly Volume891.95K

DermTech Inc (NASDAQ: DMTK) stock closed at 6.5 per share at the end of the most recent trading day (a 4.33% change compared to the prior day closing price) with a volume of 2.95M shares and market capitalization of 194.61M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 64 people. DermTech Inc CEO is John D Dobak.

The one-year performance of DermTech Inc stock is -86.16%, while year-to-date (YTD) performance is -58.86%. DMTK stock has a five-year performance of %. Its 52-week range is between 4.18 and 48.32, which gives DMTK stock a 52-week price range ratio of 5.26%

DermTech Inc currently has a PE ratio of -1.50, a price-to-book (PB) ratio of 0.71, a price-to-sale (PS) ratio of 11.03, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -37.01%, a ROC of -38.67% and a ROE of -40.57%. The company’s profit margin is -%, its EBITDA margin is -702.60%, and its revenue ttm is $13.03 Million , which makes it $0.44 revenue per share.

Of the last four earnings reports from DermTech Inc, there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-1.02 for the next earnings report. DermTech Inc’s next earnings report date is 03rd Aug 2022.

The consensus rating of Wall Street analysts for DermTech Inc is Strong Buy (1), with a target price of $26.75, which is +311.54% compared to the current price. The earnings rating for DermTech Inc stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DermTech Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DermTech Inc has a Neutral technical analysis rating based on Technical Indicators (ADX : 30.86, ATR14 : 0.65, CCI20 : 52.79, Chaikin Money Flow : 0.21, MACD : -0.54, Money Flow Index : 65.60, ROC : 2.20, RSI : 52.33, STOCH (14,3) : 89.58, STOCH RSI : 1.00, UO : 63.77, Williams %R : -10.42), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DermTech Inc in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
4 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

DermTech Inc

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

CEO: John D Dobak

Telephone: +1 858 450-4222

Address: 11099 N. Torrey Pines Road, La Jolla 92037, CA, US

Number of employees: 64

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

57%43%

Bearish Bullish

54%46%

News

Stocktwits